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Abstract 
Immune system provides us protection from infectious pathogens and tumors formation during 
lifetime. Cervical cancer (CC), and its cause, human papillomavirus (HPV) are both challenges 
for the immune system. We present here evidence of epigenetic activation of immune system 
genes in CC. Illumina Infinium Human Methylation 450 K BeadChip identified genes, which 
were all significantly hypomethylated in CC tissue versus normal tissue. The GeneMANIA 
computer program identified a tight network between those genes. The most strongly correlated 
genes based on their function are immune effectors’ process (AIM2, BST2, BTN3A3, and 
IL12RB1) and response to virus related genes (AIM2, BST2, and IL12RB1). Thus, activation of 
those genes through demethylation is probably triggered by HPV oncogenes. In conclusion, the 
immune system of women who do not develop CC is probably activated earlier through DNA 
demethylation.         
 
 
Keywords 
Immunity, cancer, HPV, gene, hypomethylation  
 
Milutin Gašperov, N.; Farkas, S. A.; Nilsson, T. K; Grce, M. Epigenetic activation of immune genes in 
cervical cancer. // Immunology letters. 14 (2014), S0165; 1-2. DOI: 10.1016/j.imlet.2014.09.019 
Accepted Manuscript 
 
2 
 
Highlights  
 Study group included normal, neoplastic and cancer cervical samples.  
 Group of immune system genes were significantly hypometylated in cancer samples. 
 Genes are well networked and related to HPV infection response. 
 We underscore the importance of epigenetically driven immune response. 
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Letter to the Editor  
 Protection from infectious pathogens largely results from the coordinated interaction of 
the cells and molecules of the mammalian immune system. Key cellular components of the 
adaptive immune system are white blood cells. Both B and T lymphocytes share features of 
adaptive immunity that includes the ability to recognize pathogen components via clonal 
expression of a unique cell surface receptor. In the 1950s, Burnet and Thomas proposed the 
concept of immune surveillance of cancer. This physiological function would have the ability 
to recognize tumor cells as abnormal cells and to destroy them before they develop into 
malignant, detectable tumors. Tumor immune escape is presented through tumor growth, 
invasion, and metastasis. Thus, tumor cells developed different mechanisms to escape immune 
system such as defect of expression of antigens on the tumor cell surface, the production of 
immunosuppressive molecules and resistance to apoptosis [1].  
 The third most common cancer among women worldwide is cervical cancer (CC). Up 
to ten and more years are necessary for the development of precancerous lesions, the cervical 
intraepithelial neoplasia (CIN) that precede CC [2]. Human papillomaviruses (HPVs) are well 
established causative agents of CC, and also other anogenital tumors and head and neck 
carcinomas [2]. To date, more than 150 HPV types have been identified among which 40 infect 
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the anogenital tract including 12 having high carcinogenic potential (also named high-risk, HR) 
[3]. Although a majority of women are infected with HPV during their sexual life, merely a 
minority develop CC. Actually, only long lasting HR HPV infection will progress to CIN and 
further to cancer, but only 1/3 of HPV infected women develop an innate immune response to 
HPV [3]. Thus, it is still unknown why some women develop CC and others not, and what is 
the extent of the immune system in cervical cancerogenesis.  
 Generally HPV develops several mechanisms to evade the host’s immune system. The 
presentation of viral antigens to the host immune system is limited as HPV infection is restricted 
to epithelial cells [4]. Furthermore, HPV does not kill or destroy infected cells but is shed when 
those cells undergo programmed apoptosis, and in addition, during infection there is no 
inflammation. Still, despite all the mechanisms of immune evasion that HPV employs, adaptive 
immunity does play a role in the clearance of the infection. In specific cell-mediated immune 
response dendritic cells from the cervical epithelium play an important role in recognizing 
HPV-infected cells and stimulate T helper 1 (Th1) cells, which elicits the production of 
cytotoxic T lymphocytes [5]. In addition, innate immunity activates interferon response, 
macrophages and natural killer (NK) cells and plays a significant role in activating and directing 
adaptive immunity for the virus clearance [6].  
 There is emerging evidence suggesting that epigenetic changes such as histone 
modifications and DNA methylation play a key role in controlling the distinct transcriptional 
profiles of memory lymphocytes and thus in shaping their function [7]. In addition, those 
epigenetic mechanisms are probably involved in antigen presentation, self/nonself 
discrimination, and the balance between tolerance and autoimmunity [8]. 
 Herein, we provide strong evidence that there is an epigenetic activation of genes 
involved in the immune system response in CC tissue and, at lesser extent, in CIN3 samples 
compared to normal tissue. Our study group included 20 normal cytological smears, 19 CIN3 
and 6 CC. DNA isolation and HPV genotyping was previously described by Milutin-Gasperov 
et al. [9]. DNA methylation measured by the genome-wide assay Illumina Infinium Human 
Methylation 450 K BeadChip (Illumina, Sweden) was recently described by Farkas et al. [10]. 
Among other findings, we identified a group of genes statistically significantly hypomethylated 
in CC samples compared with the normal tissue, which all belong to the immune response 
regulatory genes. This led us to evaluate the relationship between them. For that we used the 
GeneMANIA prediction server (http://www.genemania.org) and identified the network of 
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significantly hypomethylated genes that are AIM2, BST2, BTN3A3, CASP10, CLEC2B, CST7, 
DAPP1, EDARADD, FAM26F, GBP4, HAVCR2, HLA-DPB1, IGLL1, IL12RB1, MARCO, 
PIGB, PRTN3, S1PR4, SIGLEC12, SPTA1, STAT5A, and VPREB1 (Figure 1). The most 
strongly correlated genes based on their function are immune effectors’ process (AIM2, BST2, 
BTN3A3, and IL12RB1) and response to virus, i.e. antimicrobial defense related genes (AIM2, 
BST2, and IL12RB1). The AIM2 gene (Absent In Melanoma 2) is an inflammasome sensor that 
belongs to the PYHIN family. It is known that several microbial invaders (some DNA viruses 
and some bacteria) can gain access to the cytosol of phagocytic cells and release foreign DNA 
to trigger AIM2 and caspase-1 activation. BST2 (Bone Marrow Stromal Cell Antigen) is known 
to play an inhibitory role in viral release from infected immune cells of the host. Further, 
BTN3A3 (Butyrophilin, subfamily 3, member A3) belonging to a group of major 
histocompatibility complex (MHC)-associated genes that encode type I membrane proteins, 
plays a role in the adaptive immune response. Finally, IL12RB1 (Interleukin 12 Receptor, Beta 
1) encodes a type I transmembrane protein that belongs to the hemopoietin receptor 
superfamily. Its product is an interleukin receptor, which binds interleukin-12 (IL12) and is 
involved in its transduction. IL12 plays an important role in the activities of NK cells and T 
lymphocytes, and also has anti-angiogenic activity and the role in protective immunity to 
intracellular bacteria.  
In conclusion, the immune system genes are significantly hypomethylated in CC 
compared to normal tissue indicating that its subsequent activation is most likely a response to 
HPV oncogenes E6 and E7 that are highly expressed in advanced cancer [2]. Herein, we indicate 
that the immune system becomes significantly activated in CC at the epigenetic/DNA 
methylation level. The question remains: what would happen if immune response related genes 
were activated earlier by DNA demethylation of specific gene sites, for instance already in low-
grade cervical lesions? Moreover, our findings give a possible explanation why only a minority 
of HPV positive women develops CC. In other words, the immune system of women who do 
not develop CC may be activated earlier through DNA demethylation, and consequently elude 
cancerization. 
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Fig. 1  The tight network of statistically significant hypomethylated genes in cervical cancer 
tissues compared with the normal tissues according to GeneMANIA prediction server 
(http://www.genemania.org). The interactions found between these genes are: co-expression 
(purple lines), physical interactions (pink lines), co-localization (blue lines), genetic 
interactions (green lines), shared protein domains (grey-yellow lines) and pathway (light blue 
lines). Genes that are within a black filled circle indicate our depicted hypomethylated genes, 
while those within a grey filled circle indicate their interactions. 
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